Results with Lifescozul

Santiago Pérez - Lung Cancer- Resultados con LifEscozul™ Lung Cancer

Introduction to the case

When Mr. Santiago came to us in 2015 his diagnosis was Stage IV Lung Cancer, with brain metastasis and lymph node, cervical and mediastinal involvement.

He received chemotherapy for the treatment of his cancer but his quality of life was affected by the side effects.

He sought help from LifEscozul Group and in February 2015 he started with our Escozul treatment (the most effective formulation made with blue scorpion venom).

Let's know more details about her case and see what her progress has been in the last 6 years.

  • Clinical Data

    Santiago Pérez, 65 years old at the beginning of treatment with LifEscozul.

  • Symptomatology


  • Protocol Start

    February 2015

  • Specialist assigned to Grupo LifEscozul

    Dr. Aaron Sarmiento

  • Diagnostics

    Lung cancer (bronchogenic carcinoma, 5×4.8cm) IV with brain metastasis and lymph node, cervical and mediastinal involvement.


Mr. Santiago's diagnosis was stage IV lung cancer, with brain metastasis and lymph node, cervical and mediastinal involvement.

He was prescribed chemotherapy sessions to treat his disease, and as a consequence he lost his hair and his quality of life was affected by the side effects of this treatment.

He searched the internet for other options that could help him with his disease and it was when he found LifEscozul Group that he sent us all his documentation so that our Medical Team could evaluate it. Her admission to the Protocol was approved and she started her treatment with LifEscozul (escozul, blue scorpion venom, escoazul) in February 2015.

Evolution with LifEscozul and actual results


In mid-March 2015, CT scan showed stability of the disease at the lung level.

The CT scan of May 2015 revealed a decrease of the primary tumor in the lung, with slight growth of the lymph node involvement.

In July 2015 there was evidence of a decrease in the size of the tumor lesion. The examination on July 20 reported a decrease in the lung tumor mass to 4.6×3.5cm, and stability in the lymph node metastases.

During the following months of 2015, Mr. Santiago's blood tests remained in normal ranges without presenting any change in his physical condition.


In CT and MRI performed in February 2016, moderate regression of brain lesions was observed, although with a slight increase in lung mass and lymph node lesions, so a dose readjustment was immediately performed.

Mr. Santiago continued without physical evidence of the disease.

A new MRI performed in June 2016 showed stability in the only brain lesion.

A new PET-CT scan performed in July 2016 showed complete regression of the disease, with no pulmonary or lymph node tumor lesions, only a slight right pulmonary enhancement was observed.

In PET-CT of December 2016, no change was observed with respect to July, maintaining the right pulmonary enhancement.


In PET-CT of October 2017 the examination concluded that, "No metabolic lesions suggesting the presence of macroscopic tumor activity are appreciated".

This indicated that after 2 years and 8 months of treatment with LifEscozul (the most effective formulation made with blue scorpion venom) in conjunction with other treatments, the size of the lesions has been reduced to the level that they are not detectable by a PET-CT scan.

This is a positive result that undoubtedly extended Mr. Santiago's survival prospects, despite being a type of cancer that had already advanced to the brain for more than 2 years.


In the May 2018 report, Mr. Santiago remained stable, with no evidence of tumor lesions.

This same result is ratified in PET-CT of October 2018.


The study is repeated in January 2019, without finding tumor lesions.

The June 2019 control showed that: "no hypermetabolic lesions suggesting the presence of macroscopic tumor activity".

By December 2019, no significant changes were observed in his results, Mr. Santiago's evolution was still very positive.


The report received in January 2020 did not identify hyperintense lesions in the cerebral hemispheres, brainstem or cerebellum.

In May 2020, the PET-CT scan again confirmed that Mr. Santiago was free of cancerous lesions, and by November 2020 the results remained the same.


In February 2015, Mr. Santiago started the LifEscozul treatment (escozul, blue scorpion venom, escoazul), and his blood tests have remained stable and in normal parameters during the whole treatment period.

In spite of having undergone several chemotherapy and immunotherapy treatments, he has not felt the side effects of these treatments.

Together with the conventional treatments, it has been possible to help Mr. Santiago to eliminate the pulmonary and ganglion lesions and to reduce and maintain stable the cerebral affectation.

His daily life, thanks to the combination of LifEscozul (the most effective formulation made with blue scorpion venom) and traditional therapy, has not been affected at all: he exercises regularly, walks several kilometers and does not get tired.

We are the LifEscozul Group and the Results Define Us.

Next case

Raúl Manzano Murillo - Thyroid Cancer- Resultados con LifEscozul™

Raúl Manzano Murillo

Raul was detected with thyroid cancer in 2016 and underwent surgery in April 2016 for papillary thyroid carcinoma. At the end of 2017 he was detected new tumor nodules on both sides of his neck, with no possibility of operation due to fibrosis following surgery and iodotherapies received, he was offered no treatment option. View more